Investigation of the Effects of Zebularine on Caspase-3 and Caspase-9 Involved in Anticancer and Apoptotic Mechanisms in SKBR3 Breast Cancer Cell Line — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Investigation of the Effects of Zebularine on Caspase-3 and Caspase-9 Involved in Anticancer and Apoptotic Mechanisms in SKBR3 Breast Cancer Cell Line
Department of Molecular Biology and Genetics, Faculty of Science and Letters, Bilecik Seyh Edebali University, Bilecik, Turkey
,
Biotechnology Research and Application Center, Bilecik Seyh Edebali University, Bilecik, Turkey
,
Vocational School of Medical Services, Program of Medical Laboratory Techniques, Bilecik Seyh Edebali University, Bilecik, Turkey
1 Department of Molecular Biology and Genetics, Faculty of Science and Letters, Bilecik Seyh Edebali University, Bilecik, Turkey
2 Biotechnology Research and Application Center, Bilecik Seyh Edebali University, Bilecik, Turkey
3 Vocational School of Medical Services, Program of Medical Laboratory Techniques, Bilecik Seyh Edebali University, Bilecik, Turkey
The aim of this study is to investigate the anti-proliferative effects of Zebularine on caspase-3 and 9 genes by methylation and protein expression on SKBR3 cells. The SKBR3 cells were treated with Zebularine at different concentrations (0 - 140 μM) for 24 - 96 hours and the effects on the cell viability were shown. The effects on the cell migration and cell transformation were also demonstrated at the specified dose (IC 50 = 40 μM). At the same time, the HRM method and western-blot analysis were used to understand the effects in the apoptotic mechanism. According to the obtained results, it was observed that Zebularine significantly decreased the cell proliferation, cell migration and the cell growth (p < 0.001). As a result of the methylation analyzes performed on SKBR-3 cells at the applied dose, it was observed that Zebularine caused a decrease in both caspase-3 and 9 methylation rates at the 72 nd hour. However, both reductions in the methylation levels didn’t cause a significant change (p > 0.05). At the same time, it was detected by the western-blot analyses that there was a time dependent increase in caspase-3 genes while a decrease was detected in the caspase-9 gene in progress of time. The obtained results showed that the methylation changes occurring in the caspase genes weren’t related to the protein levels. According to these results, supportive results a re obtained showing that the Zebularine c an be used in chemotherapy and that this study is unique since it is the first study in the li terature intending to investigate the effects of Zebularine on the SKBR3 cells .
KeywordsSKBR3ZebularineApoptosisBreast Cancer
Jemal, A., Siegel, R., Xu, J. and Ward, E. (2010) Cancer Statistics, 2010. CA: A Cancer Journal for Clinicians, 60, 277-300. https://doi.org/10.3322/caac.20073
Curado, M.P., Edwards, B., Shin, H.R., Storm, H., Ferlay, J., Heanue, M. and Boyle, P. (2007) Cancer Incidence in Five Continents. IARC Press, International Agency for Research on Cancer, Lyon, Vol. 9.
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M. and Bray, F. (2015) Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. International Journal of Cancer, 136, E359-E386. https://doi.org/10.1002/ijc.29210
Moongkarndi, P., Kosem, N., Kaslungka, S., Luanratana, O., Pongpan, N. and Neungton, N. (2004) Antiproliferation, Antioxidation and Induction of Apoptosis by Garcinia mangostana (Mangosteen) on SKBR3 Human Breast Cancer Cell Line. Journal of Ethnopharmacology, 90, 161-166. https://doi.org/10.1016/j.jep.2003.09.048
Olsson, M. and Zhivotovsky, B. (2011) Caspases and Cancer. Cell Death and Differentiation, 18, 1441-1449. https://doi.org/10.1038/cdd.2011.30
Kerr, J.F., Wyllie, A.H. and Currie, A.R. (1972) Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics. British Journal of Cancer, 26, 239-257. https://doi.org/10.1038/bjc.1972.33
Fischer, U., Janssen, K. and Schulze-Osthoff, K. (2007) Does Caspase Inhibition Promote Clonogenic Tumor Growth? Cell Cycle, 6, 3048-3053. https://doi.org/10.4161/cc.6.24.5118
Lu, Y. and Chen, G.Q. (2011) Effector Caspases and Leukemia. International Journal of Cell Biology, 2011, Article ID: 738301. https://doi.org/10.1155/2011/738301
Boatright, K.M., Renatus, M., Scott, F.L., Sperandio, S., Shin, H., Pedersen, I.M. and Salvesen, G.S. (2003) A Unified Model for Apical Caspase Activation. Molecular Cell, 11, 529-541. https://doi.org/10.1016/S1097-2765(03)00051-0
Degterev, A., Boyce, M. and Yuan, J. (2003) A Decade of Caspases. Oncogene, 22, 8543-8567. https://doi.org/10.1038/sj.onc.1207107
O’Donovan, N., Crown, J., Stunell, H., Hill, A.D., McDermott, E., O’Higgins, N. and Duffy, M.J. (2003) Caspase 3 in Breast Cancer. Clinical Cancer Research, 9, 738-742.
Keane, M.M., Ettenberg, S.A., Nau, M.M., Russell, E.K. and Lipkowitz, S. (1999) Chemotherapy Augments TRAIL-Induced Apoptosis in Breast Cell Lines. Cancer Research, 59, 734-741.
Bellarosa, D., Ciucci, A., Bullo, A., Nardelli, F., Manzini, S., Maggi, C.A. and Goso, C. (2001) Apoptotic Events in a Human Ovarian Cancer Cell Line Exposed to Anthracyclines. Journal of Pharmacology and Experimental Therapeutics, 296, 276-283.
Estrov, Z., Thall, P.F., Talpaz, M., Estey, E.H., Kantarjian, H.M., Andreeff, M. and Kornblau, S.M. (1998) Caspase 2 and Caspase 3 Protein Levels as Predictors of Survival in Acute Myelogenous Leukemia. Blood, 92, 3090-3097.
Pu, X., Storr, S.J., Zhang, Y., Rakha, E.A., Green, A.R., Ellis, I.O. and Martin, S.G. (2017) Caspase-3 and Caspase-8 Expression in Breast Cancer: Caspase-3 Is Associated with Survival. Apoptosis, 22, 357-368. https://doi.org/10.1007/s10495-016-1323-5
Winter, R.N., Kramer, A., Borkowski, A. and Kyprianou, N. (2001) Loss of Caspase-1 and Caspase-3 Protein Expression in Human Prostate Cancer. Cancer Research, 61, 1227-1232.
Blanc, C., Deveraux, Q.L., Krajewski, S., Janicke, R.U., Porter, A.G., Reed, J.C. and Marti, A. (2000) Caspase-3 Is Essential for Procaspase-9 Processing and Cisplatin-Induced Apoptosis of MCF-7 Breast Cancer Cells. Cancer Research, 60, 4386-4390.
Yang, X.H., Sladek, T.L., Liu, X., Butler, B.R., Froelich, C.J. and Thor, A.D. (2001) Reconstitution of Caspase 3 Sensitizes MCF-7 Breast Cancer Cells to Doxorubicin-and Etoposide-Induced Apoptosis. Cancer Research, 61, 348-354.
Teitz, T., Wei, T., Valentine, M.B., Vanin, E.F., Grenet, J., Valentine, V.A. and Kidd, V.J. (2000) Caspase 8 Is Deleted or Silenced Preferentially in Childhood Neuroblastomas with Amplification of MYCN. Nature Medicine, 6, 529-535. https://doi.org/10.1038/75007
Shivapurkar, N., Toyooka, S., Eby, M.T., Huang, C.X., Sathyanarayana, U.G., Cunningham, H.T. and Chaudhary, P.M. (2013) Differential Inactivation of Caspase-8 in Lung Cancers. Cancer Biology and Therapy, 14, 1074. https://doi.org/10.4161/cbt.26923
Soengas, M.S., Alarcon, R.M., Yoshida, H., Hakem, R., Mak, T.W. and Lowe, S.W. (1999) Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition. Science, 284, 156-159. https://doi.org/10.1126/science.284.5411.156
Champion, C., Guianvarc’h, D., Sénamaud-Beaufort, C., Jurkowska, R.Z., Jeltsch, A., Ponger, L. and Guieysse-Peugeot, A.L. (2010) Mechanistic Insights on the Inhibition of c5 DNA Methyltransferases by Zebularine. PloS ONE, 5, e12388. https://doi.org/10.1371/journal.pone.0012388
Yoo, C.B., Cheng, J.C. and Jones, P.A. (2004) Zebularine: A New Drug for Epigenetic Therapy.
Pompeia, C., Hodge, D.R., Plass, C., Wu, Y.Z., Marquez, V.E., Kelley, J.A. and Farrar, W.L. (2004) Microarray Analysis of Epigenetic Silencing of Gene Expression in the KAS-6/1 Multiple Myeloma Cell Line. Cancer Research, 64, 3465-3473. https://doi.org/10.1158/0008-5472.CAN-03-3970
Napso, T. and Fares, F. (2014) Zebularine Induces Prolonged Apoptosis Effects via the Caspase-3/PARP Pathway in Head and Neck Cancer Cells. International Journal of Oncology, 44, 1971-1979. https://doi.org/10.3892/ijo.2014.2386
Candiloro, I.L., Mikeska, T., Hokland, P. and Dobrovic, A. (2008) Rapid Analysis of Heterogeneously Methylated DNA Using Digital Methylation-Sensitive High Resolution Melting: Application to the CDKN2B (p15) Gene. Epigenetics & Chromatin, 1, 7. https://doi.org/10.1186/1756-8935-1-7
Martens, J.W., Margossian, A.L., Schmitt, M., Foekens, J. and Harbeck, N. (2009) DNA Methylation as a Biomarker in Breast Cancer. Future Oncology, 5, 1245-1256. https://doi.org/10.2217/fon.09.89
Bradbury, J. (2004) Zebularine: A Candidate for Epigenetic Cancer Therapy. Drug Discovery Today, 9, 906-907. https://doi.org/10.1016/S1359-6446(04)03266-0
Cheng, J.C., Yoo, C.B., Weisenberger, D.J., Chuang, J., Wozniak, C., Liang, G. and Jones, P.A. (2004) Preferential Response of Cancer Cells to Zebularine. Cancer Cell, 6, 151-158. https://doi.org/10.1016/j.ccr.2004.06.023
Yang, P.M., Lin, Y.T., Shun, C.T., Lin, S.H., Wei, T.T., Chuang, S.H. and Chen, C.C. (2013) Zebularine Inhibits Tumorigenesis and Stemness of Colorectal Cancer via p53-Dependent Endoplasmic Reticulum Stress. Scientific Reports, 3, 3219. https://doi.org/10.1038/srep03219
Ruiz-Magana, M.J., Rodríguez-Vargas, J.M., Morales, J.C., Saldivia, M.A., Schulze-Osthoff, K. and Ruiz-Ruiz, C. (2012) The DNA Methyltransferase Inhibitors Zebularine and Decitabine Induce Mitochondria-Mediated Apoptosis and DNA Damage in p53 Mutant Leukemic T Cells. International Journal of Cancer, 130, 1195-1207. https://doi.org/10.1002/ijc.26107
Nakamura, K., Nakabayashi, K., Aung, K.H., Aizawa, K., Hori, N., Yamauchi, J. and Tanoue, A. (2015) DNA Methyltransferase Inhibitor Zebularine Induces Human Cholangiocarcinoma Cell Death through Alteration of DNA Methylation Status. PloS ONE, 10, e0120545. https://doi.org/10.1371/journal.pone.0120545
Tan, W., Zhou, W., Yu, H.G., Luo, H.S. and Shen, L. (2013) The DNA Methyl-transferase Inhibitor Zebularine Induces Mitochondria-Mediated Apoptosis in Gastric Cancer Cells in Vitro and in Vivo. Biochemical and Biophysical Research Communications, 430, 250-255. https://doi.org/10.1016/j.bbrc.2012.10.143
Balch, C., Yan, P., Craft, T., Young, S., Skalnik, D.G., Huang, T.H. and Nephew, K.P. (2005) Antimitogenic and Chemosensitizing Effects of the Methylation Inhibitor Zebularine in Ovarian Cancer. Molecular Cancer Therapeutics, 4, 1505-1514. https://doi.org/10.1158/1535-7163.MCT-05-0216
Yamaguchi, H., Wyckoff, J. and Condeelis, J. (2005) Cell Migration in Tumors. Current Opinion in Cell Biology, 17, 559-564. https://doi.org/10.1016/j.ceb.2005.08.002
Hellebrekers, D.M., Jair, K.W., Viré, E., Eguchi, S., Hoebers, N.T., Fraga, M.F. and Griffioen, A.W. (2006) Angiostatic Activity of DNA Methyltransferase Inhibitors. Molecular Cancer Therapeutics, 5, 467-475. https://doi.org/10.1158/1535-7163.MCT-05-0417
Zhou, P., Lu, Y. and Sun, X.H. (2012) Effects of a Novel DNA Methyltransferase Inhibitor Zebularine on Human Lens Epithelial Cells. Molecular Vision, 18, 22.
Salvesen, G.S. and Riedl, S.J. (2008) Caspase Mechanisms. In: White, R.K.-F., Ed., Programmed Cell Death in Cancer Progression and Therapy, Springer, Dordrecht, 13-23. https://doi.org/10.1007/978-1-4020-6554-5_2
Parrish, A.B., Freel, C.D. and Kornbluth, S. (2013) Cellular Mechanisms Controlling Caspase Activation and Function. Cold Spring Harbor Perspectives in Biology, 5, a008672. https://doi.org/10.1101/cshperspect.a008672
Nakamura, K., Aizawa, K., Nakabayashi, K., Kato, N., Yamauchi, J., Hata, K. and Tanoue, A. (2013) DNA Methyltransferase Inhibitor Zebularine Inhibits Human Hepatic Carcinoma Cells Proliferation and Induces Apoptosis. PloS ONE, 8, e54036. https://doi.org/10.1371/journal.pone.0054036
Eroglu, O., Baysak, M.E., Aras, B.D., Cilingir, O. and Artan, S. (2018) Detection of Promoter Hypermethylation of GSTP1 and CDH1 Genes and the Relationship of Histopathological Parameters of the Breast. Advances in Breast Cancer Research, 7, 91-106. https://doi.org/10.4236/abcr.2018.72006